Advertisement
Screener

AIMEI HEALTH TECHNOLOGY CO., LTD (AFJK) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

AIMEI HEALTH TECHNOLOGY CO., LTD Financing Cash Flow

AIMEI HEALTH TECHNOLOGY CO., LTD (AFJK) reported Financing Cash Flow of $401.70 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13

  • AIMEI HEALTH TECHNOLOGY CO., LTD net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $242.84K, a 62.44% decline year-over-year.
  • AIMEI HEALTH TECHNOLOGY CO., LTD net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $158.86K.
  • AIMEI HEALTH TECHNOLOGY CO., LTD net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$33.65M.
  • AIMEI HEALTH TECHNOLOGY CO., LTD net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $546.95K.
  • AIMEI HEALTH TECHNOLOGY CO., LTD net cash provided by (used in) financing activities for fiscal 2025 was -$63.04M, a 15959.95% decline from fiscal 2024.
  • AIMEI HEALTH TECHNOLOGY CO., LTD net cash provided by (used in) financing activities for fiscal 2024 was $397.48K.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 5 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 8 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30$242.84K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$401.70K
10-Q · filed 2026-08-13
-$33.25M
derived: sum of 3 quarters · filed 2026-08-13
-$32.70M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$158.86K
10-Q · filed 2026-06-16
-$33.49M
derived: sum of 2 quarters · filed 2026-06-16
-$32.94M
derived: sum of 3 quarters · filed 2026-06-16
-$32.30M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$33.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-04
-$33.10M
derived: sum of 2 quarters · filed 2026-05-04
-$32.46M
derived: sum of 3 quarters · filed 2026-08-13
-$63.04M
10-K · filed 2026-05-04
2025-09-30$546.95K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18
$1.19M
derived: sum of 2 quarters · filed 2026-08-13
-$29.39M
10-Q · filed 2025-11-18
2025-06-30$646.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$29.94M
10-Q · filed 2026-08-13
2025-03-31-$30.58M
10-Q · filed 2026-06-16
2024-12-31$397.48K
10-K · filed 2026-05-04
2023-12-31$70.27M
10-K/A · filed 2025-08-26
2023-09-30$10.00K
10-Q · filed 2024-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
CO2 Energy Transition Corp. (NOEM)United States$0.040B
Israel Acquisitions Corp (ISRL)United States$0.032B
Innventure, Inc. (INV)United States$0.068B-2.99
Origin Investment Corp I (ORIQ)$0.090B13.93
XFLH Capital Corp (XFLH)United States$0.139B
Aldel Financial II Inc. (ALDF)United States$0.323B